Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richa Singhal

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Jmirx Med|May 25, 2021
Mobile App-Reported Use of Traditional Medicine for Maintenance of Health in India During the COVID-19 Pandemic: Cross-sectional Questionnaire StudyN Srikanth, Rakesh Rana, Richa Singhal, et al.
Physiological Reports|November 18, 2025
Fibroblast Has2 limits acute heart failure following myocardial infarction in male miceDanielle T Little, Kenneth R Brittian, Caitlin Howard, et al.
Ayu|June 22, 2023
<i>Swasthya</i> Assessment Scale (SAS)-<i>Ayurveda</i> based health assessment tool-insights on its development and validationJaiprakash Bholanath Ram, Babita Yadav, V Ashwathykutty, et al.
Frontiers in Public Health|July 28, 2022
Disease Characteristics, Care-Seeking Behavior, and Outcomes Associated With the Use of AYUSH-64 in COVID-19 Patients in Home Isolation in India: A Community-Based Cross-Sectional AnalysisNarayanam Srikanth, Adarsh Kumar, Bhogavalli Chandrasekhararao, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
The Nox2 NADPH oxidase regulates neutrophilic inflammation in the oral cavityShunying Jin, Richa Singhal, Jianzhu Luo, et al.
Complementary Therapies in Medicine|February 12, 2022
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, IndiaHarbans Singh, Sumit Srivastava, Babita Yadav, et al.
JMIR Research Protocols|April 29, 2026
Efficacy of Ayurveda Regimen as an Adjunct to Hydroxyurea in Sickle Cell Disease: Protocol for a Prospective, Randomized, Open-Label, Blinded End Point Exploratory StudyDanish Javed, Amit Kumar Rai, Sachin Bansal, et al.
Journal of Ayurveda and Integrative Medicine|January 15, 2021
AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot studyManohar S Gundeti, Laxman W Bhurke, Pallavi S Mundada, et al.
Journal of Ayurveda and Integrative Medicine|December 31, 2021
Author's reply to correspondence 'influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation'Manohar S Gundeti, Laxman W Bhurke, Pallavi S Mundada, et al.
Gut Microbes|August 9, 2021
Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in miceRicha Singhal, Hridgandh Donde, Smita Ghare, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Jmirx Med|May 25, 2021
Mobile App-Reported Use of Traditional Medicine for Maintenance of Health in India During the COVID-19 Pandemic: Cross-sectional Questionnaire StudyN Srikanth, Rakesh Rana, Richa Singhal, et al.
Physiological Reports|November 18, 2025
Fibroblast Has2 limits acute heart failure following myocardial infarction in male miceDanielle T Little, Kenneth R Brittian, Caitlin Howard, et al.
Ayu|June 22, 2023
<i>Swasthya</i> Assessment Scale (SAS)-<i>Ayurveda</i> based health assessment tool-insights on its development and validationJaiprakash Bholanath Ram, Babita Yadav, V Ashwathykutty, et al.
Frontiers in Public Health|July 28, 2022
Disease Characteristics, Care-Seeking Behavior, and Outcomes Associated With the Use of AYUSH-64 in COVID-19 Patients in Home Isolation in India: A Community-Based Cross-Sectional AnalysisNarayanam Srikanth, Adarsh Kumar, Bhogavalli Chandrasekhararao, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
The Nox2 NADPH oxidase regulates neutrophilic inflammation in the oral cavityShunying Jin, Richa Singhal, Jianzhu Luo, et al.
Complementary Therapies in Medicine|February 12, 2022
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, IndiaHarbans Singh, Sumit Srivastava, Babita Yadav, et al.
JMIR Research Protocols|April 29, 2026
Efficacy of Ayurveda Regimen as an Adjunct to Hydroxyurea in Sickle Cell Disease: Protocol for a Prospective, Randomized, Open-Label, Blinded End Point Exploratory StudyDanish Javed, Amit Kumar Rai, Sachin Bansal, et al.
Journal of Ayurveda and Integrative Medicine|January 15, 2021
AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot studyManohar S Gundeti, Laxman W Bhurke, Pallavi S Mundada, et al.
Journal of Ayurveda and Integrative Medicine|December 31, 2021
Author's reply to correspondence 'influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation'Manohar S Gundeti, Laxman W Bhurke, Pallavi S Mundada, et al.
Gut Microbes|August 9, 2021
Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in miceRicha Singhal, Hridgandh Donde, Smita Ghare, et al.
Pageof 8